Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Esketamine-Propofol Versus Sufentanil-Propofol Sedation on Hypoxemia and Hypotension During Endoscopic Retrograde Cholangiopancreatography (ERCP)

NCT07702240 is registered in ClinicalTrials.gov with Ren Da as lead sponsor.

NCT NCT07702240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07702240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Esketamine-Propofol Versus Sufentanil-Propofol Sedation on Hypoxemia and Hypotension During Endoscopic Retrograde Cholangiopancreatography (ERCP)
Lead sponsor
Ren Da
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 10, 2026
Completion date
March 10, 2028
Enrollment
530 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract diseases, procedural sedation and analgesia